About us

Our origin story

It all started with a shift of mindset.

What if we can truly see and understand what our immune system is seeing? What if we can leverage our immune system to generate therapeutics, develop diagnostics, and monitor patients?

Omniscope was founded in 2020, by a multidisciplinary team of scientists and professionals who wanted to be of service to humanity at a critical moment for our species. We observed that “modern” medicine is using tools that tend to be too narrowly focused, time-consuming and misrepresenting. Too many groundbreaking scientific discoveries stay in the research field instead of helping patients.

What emerged is a technology based on the convergence between AI and immunology - to bring our humanistic vision of health equity to life. A mission-driven technology to put science in service of humanity.

The future of diagnostics & therapeutics.

See what your immune system is seeing.

Healthcare for everyone, everywhere.

Science is we all.

Executive Team

Dr. Holger Heyn

Scientific Co-Founder

Dr. Holger leads the Single Cell Genomics Group at the Spanish National Centre for Genomic Analysis (one of Europe’s largest Genome Centres). He has co-authored over 80 publications, and his research has received over €7.5m funding from (inter)national agencies. Dr. Holger is a key opinion leader in the field of Genomics, a member of the Human Cell Atlas project and a partner of the LifeTime Initiative.

Vijay views technology as fundamental to humanity. He has been part of scaling companies such as Illumina and 10X Genomics. He has acquired and commercialised disruptive diagnostic technologies during his leadership at Siemens Healthineers and Meridian Biosciences. Vijay has been part of important IPOs in the biotechnology industry and finds his passion in improving health by the application of technology.

Vijay Vaswani

Co-Founder & CEO

Vijay views technology as fundamental to humanity. He has been part of scaling companies such as Illumina and 10X Genomics. He has acquired and commercialised disruptive diagnostic technologies during his leadership at Siemens Healthineers and Meridian Biosciences. Vijay has been part of important IPOs in the biotechnology industry and finds his passion in improving health by the application of technology.

Lynnette Ang

Co-Founder & Chief Growth Officer

Lynnette brings to Omniscope her experience in the financial sector, where she served a diverse client base at Aberdeen Asset Management. These spanned government, private and public financial institutions including Sovereign Wealth Funds, Global Pensions, Central Banks, Insurers as well as Independent intermediates, global banks and online fund platforms.

Matthew Sant

Chief Information Officer

Matthew wrote his first program on a 1982 BBC Micro Model B at the age of 4. After more than 20 years of working in all aspects of software, in both startups and multinationals, across a wide spectrum of industries ranging from warehouse robotics to hedge funds, Matthew is still as excited about tech today as he was back then.

Our advisors

Dr. Joan Seoane

Director, Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO)

Preclinical and Translational Research program Director at the Vall d'Hebron Institute of Oncology (VHIO) within the Vall d'Hebron Hospital, Barcelona, Spain, since 2011. In 1998, he obtained his PhD from the University of Barcelona and joined the Memorial Sloan-Kettering Cancer Center (MSKCC) in New York as a post-doctoral fellow (first as a Research Fellow and then Research Associate since 2001). He was appointed ICREA Professor in 2004 and joined VHIO. In 2008, he was the recipient of a European Research Council (ERC) grant, became Board member of the European Association of Cancer Research (EACR) and Professor at Universitat Autònoma de Barcelona. In 2012, he founded Mosaic Biomedicals as a spin-off company from his lab. In 2016, he became Secretary General of the EACR.

Dr. Ivo Gut

Director, Centro Nacional de Análisis Genómico (CNAG)

Dr. Heyn leads the Single Cell Genomics Group at the Spanish National Centre for Genomic Analysis (one of Europe’s largest Genome Centres). He has co-authored over 80 publications, and his research has received over €7.5m funding from (inter)national agencies. Dr. Heyn is a key opinion leader in the field of Genomics, a member of the Human Cell Atlas project and a partner of the LifeTime Initiative.

Dr. Christian Brander

ICREA Senior Research Professor, IrsiCaixa AIDS Research Institute & Chief Scientific Officer, AELIX Therapeutics

Dr. Luciano Martelotto

Head of Development Laboratory | Single Cell and Spatial-omics , Adelaide Centre of Epigenetics

Romain is a commercial executive with a passion for healthcare. Over the last 20 years, he held different international leadership positions at Siemens Healthineers and Erba Mannheim. He brings to Omniscope a wealth of expertise in product commercialization for in-vitro diagnostics markets and business development in emerging countries.

Dr. Fabian Theis

Director, Institute of Computational Biology & Professor, TUM mathematics and life sciences

Dr. Victor Greiff

Associate Professor, Laboratory for Computational and Systems Immunology, University of Oslo

James Hughes

Chief Executive and CIO, Vedra Partners

Simone Medin

Director, Qatar Investment Authority

Romain Fournials

Chief Commercial Officer, Erba Mannheim

We’re driven
by our values

We strive to create an ecosystem that improves people's lives.

Get In Touch

Knowledge

We know and believe in science. There’s much we don’t know, so we keep learning. From the immune system, the scientific community, nature, and beyond. To innovate, we look at things differently.

Collaboration

As scientists, collaboration feels natural. We listen to each other and nurture an ecosystem where everyone can contribute. The task is too great for one to solve, but together we can change the world.

Diversity + Inclusivity

We care about people and we want to help, starting with the vulnerable. Every day, we bring our humanity to work and let our compassion be a driver. We disrupt through inclusion.

Usefulness

We use science as a force for good. We see the human body as a tool, instead of reinventing the wheel. We simplify complex things for maximum efficiency, to have a big lasting impact.